Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-07-11 | 2022-08-19 | 164373 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2017-06-19 | 2017-08-08 | 13305 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-07-25 | 2017-09-22 | 16861 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
| APO-ATORVASTATIN | 40MG | TABLET | Avoided shortage | 2021-12-17 | 2022-01-18 | 151342 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-01-21 | 2022-03-14 | 153267 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2018-01-03 | 2018-03-05 | 34829 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2018-01-03 | 2018-03-05 | 34832 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-03-19 | 2021-04-12 | 136016 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229401 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-09-05 | 2024-11-01 | 236875 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-12-12 | 2025-01-03 | 245505 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-12-05 | 2020-01-22 | 100262 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210695 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-24 | 2023-12-01 | 211493 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2025-04-17 | 2025-05-02 | 255194 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-12-15 | 2024-04-05 | 213556 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NITRAZEPAM TABLETS BP | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
| APO-NITRAZEPAM TABLETS BP | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NORTRIPTYLINE - CAP 10MG | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NORTRIPTYLINE - CAP 25MG | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
| APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
| APO-PROPRANOLOL TAB 20MG | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
| APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |